LONDON, Dec. 31, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Biosensors in US$ Million by the following Product Segments: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors), Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 72 companies including many key and niche players such as -
Abbott Point Of Care, Inc.Animas CorporationBio-Rad Laboratories, Inc.GE Healthcare Life SciencesF. Hoffmann-La Roche Ltd.
Read the full report: http://www.reportlinker.com/p02568579-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Medical Biosensors I-3
Glucose Biosensors I-4
Other Medical Biosensors I-4
Environmental Biosensors I-4
Other Biosensors I-4
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW II-1
Strong Growth on Cards for Biosensors II-1
A Glance at Key Trends & Developments in Biosensors Market II-2
Recession Leaves Biosensors Market Unruffled II-3
Increasing Medical Applications of Biosensors II-4
Competitive Scenario II-5
Noteworthy Patent Applications for Biosensors in the Years
2013 & 2014 II-6
Competition in the Global Blood Glucose Meters Market II-6
Table 1: Leading Players in the World Blood Glucose Meters
Market (2012): Market Share Breakdown for Roche, LifeScan,
Bayer, Abbott and Others (includes corresponding
Graph/Chart) II-7
2. MARKET DYNAMICS II-8Alarming Rise in Diabetes: Favorable Prospects for BiosensorsMarket II-8Table 2: Worldwide Prevalence of Diabetes Mellitus by Region(2013 & 2035) (includes corresponding Graph/Chart) II-9
Table 3: Incidence of Diabetes in Select Countries (2013 &
2035) (includes corresponding Graph/Chart) II-10
Table 4: Global Population Statistics for the 65+ Age Group(2013E) (includes corresponding Graph/Chart) II-11Increasing Need for Testing: Potential Opportunities forBiosensors Market II-12Mobile Glucose Monitoring Devices to Drive Demand for Biosensors II-13Growth Potential Opportunities in Home & Point of Care TestingApplications II-14Rising Demand for Biosensors from POC Testing Applications II-14Biosensors in Drug Discovery - 'Catching Pace' II-15Biosensors for Cardiovascular Disease Monitoring II-15Biosensors in Cholesterol Testing: A Promising Application II-16Miniature Sensors - The Future of Cholesterol Testing II-16Biosensors Find Increasing Use in Environmental Applications II-17Setting New Frontiers for Food Safety Testing - An EmergingApplication II-18Automotive Sector Offers Sanguine Opportunities II-19Action against Biological Warfare Agents: Focus on EffectiveBiosensors II-19Growing Focus on Using Nanomaterials in Glucose Biosensors II-20Nucleic Acid-based Biosensors Find Prominence II-21Technological Innovations: Spearheading Growth in theBiosensors Market II-21Cutting-Edge Design - Order of the Day II-22Wearable Biosensors - No Longer Science Fiction! II-23Wearable Sensors for Wound Healing II-24Biosensors to Check for CO Poisoning Risk II-24Biosensors to Solve Crime II-24ESPRIT Program Initiates Biosensors for Sports Applications II-24Google's Smart Contact Lens for Diabetes Management II-25Disposable Biosensor Device to Monitor Intestine Rate II-25Self-Powered Wearable Sensors II-26Increasing R&D Activity Bodes Well for Biosensors Market II-27Air Force Research Lab to Conduct Wearable Biosensors Trialon Marathon Runners II-27Biosensors in Adhesive Bandages II-28UCSB Researchers Develop New Biosensor Material II-28Biosensor Worn on Skin Measures Lactate Levels II-28Innovative Biosensor Technologies on the Cards II-29CSIRO Develops Biosensor Platform for Dairy Sector II-29Researchers Focus on Functionalized Graphene Sheets toDevelop High-Performance Biosensors II-29Researchers Develop Biosensor Device to Identify Antibiotic-resistant Bacteria II-30Organic Thin Film Transistor-based Biosensor to Detect BrainInjury during Heart Surgeries II-30Nanotechnology-based Biosensor to Identify ListeriaMonocytogenes in Food Products II-31EU Scientists Focus on Developing Photonic Biosensors toDiagnose Food Allergies II-31ASU Researchers to Develop Biosensor Devices to IdentifyContaminated Drinking Water II-32Nano-Sized Biosensor Device to Monitor Glucose Levels withoutBlood Samples II-32NYU Researchers Develop Highly Sensitive Biosensor Device toDetect Small Single Virus Particles II-33Graphene Biosensor for Tracking Cancer Biomarkers II-33Oligonucleotide Biosensors - The Road Ahead? II-34Cell-Based Biosensors on the Rise II-35Smartphone-based Biosensors to Lead the Future? II-35smartCARD by Cornell University II-36iColour Analyser Mobile Application at University ofCalifornia, Berkeley II-36University of Rhode Island II-37University of Illinois, Urbana-Champaign II-37Rapid Diagnostic Test Reader of University of California, LosAngeles II-37Portable Biosensor Device by OJ-Bio Researchers II-37Reducing Costs - A Priority for Biosensor Manufacturers II-37Regulations Encumber Biosensors Market Growth II-38'Snail'-Paced Commercialization - An Issue to Deal with! II-38
3. PRODUCT OVERVIEW II-40
Biosensors: An Introduction II-40
Historical Perspective II-40
Components of Biosensors II-41
Receptor II-41
Transducer II-41
Separator II-41
Biological Components II-42
Attributes of a Good Biosensor II-42
Types of Biosensors II-42
Glucose Sensor II-43
Medical Telesensors II-44
Detecting Cancer and Health Abnormalities II-44
Lactate Sensor II-44
Alcohol Sensor II-44
Biochemical Oxygen Demand Sensor (BOD) II-44
Bioreporters II-44
Miniaturized Devices II-45
Classes of Biosensors II-45
Calorimetric Biosensors II-45
Potentiometric Biosensors II-45
Amperometric Biosensors II-45
Optical Biosensors II-45
Methods to Produce Optical Biosensors II-46
Simple Fiber Optic Biosensors II-46
Evanescent Wave System II-46
Surface Plasmon Resonance (SPR) II-46
Piezoelectric Biosensors II-46
Other Physicochemical Biosensors II-46
4. A GLANCE AT MAJOR APPLICATION AREAS II-47A. Medical Applications II-47Glucose Meters II-47Categorization II-47Biosensors in Home Glucose Monitors II-47PBGM Devices: Based on Photometric or Biosensor Technology II-48Non-Invasive Products II-48Blood Gas Market II-49Sensors Facilitate Analysis of Blood II-49DNA Biosensors and Genechips: A Relatively Nascent Market II-50B. Environmental Biosensors II-50C. Industrial Applications II-51Summarization of Available Biosensors & TechnologicalApplications II-52Biological Warfare: An Increasingly Important Area forBiosensors II-52Biosensors in Food Industry II-52Biosensors: Speeding Pathogen Detection II-53
5. PATENT GRANTS/FILINGS/SUBMISSIONS II-54
Eyesense Submits Application for Patent on Using Hydrogels for
Biosensors II-54
Bioglow Seeks Patent for Biosensors II-54
Abbott Bags US Patent for Biosensors II-54
Agency Science Tech & Res Files Patent for Recombinant Protein
Biosensors II-54
Profusa Seeks Patent for Tissue Integrating Sensors II-54
LifeScan Bags Patent for Systems & Devices to Improve
Biosensors Accuracy II-54
Bayer Healthcare Wins Patent on Biosensors II-54
Roche Diagnostics Wins Patent for Biosensor with Predetermined
Dose Response Curve II-55
Microchips Granted Patent on Multi-Channel Potentiostat for
Biosensor Arrays II-55
Delbio Seek Patent for Biosensors II-55
Dow Corning Files Patent to Form Semipermeable Membranes for
Sensor Applications II-55
Protein Technologies Seeks Patent on Biosensors II-55
Lifescan Scotland Files Patent for Using VDAT Nanoparticles in
Biosensors II-55
LG and Researchers Seek Patent for Reagent Composition of
Biosensors II-55
Tyson Bioresearch Bags Patent for Method to Increase Coding
Information for Biosensors II-56
Nova Biomedical Granted Patent for Electrochemical Biosensors II-56
Endotronix Receives Patent for Wireless Reading of Biosensor
Implants II-56
6. PRODUCT LAUNCHES/INNOVATIONS II-57Propeller Health Receives FDA Approval for Mobile HealthSensor Devices II-57dorsaVi Receives FDA Clearance for ViMove Wearable Biosensor II-57Nano Labs Develops New Miniaturized Tuberculosis Biosensor-Based Diagnostic Technology II-57Biosensors International Group Receives CE Mark Approval forBioFreedom™ II-57Dexcom Receives FDA Approval for Dexcom G4 Platinum Device II-57ForteBio Launches Dip and Read Ni-NTA Biosensors II-57EMD Millipore Unveils LentiBrite Lentiviral Biosensors II-57Proteus Digital Health Receives FDA Approval for IngestibleSensor II-58PositiveID Corporation Finalizes Development of GlucoChip™ II-58Meder Unveils MK23 Line of Sensors II-58Honeywell Unveils NBP Series Pressure Sensors II-58
7. RECENT INDUSTRY ACTIVITY II-59
Intuitive Surgical Acquires Luna's Shape-sensing Technology
for Medical Applications II-59
Citic Group Acquires Stake in Shandong Weigao Group Medical
Polymer II-59
ForteBio Selects MBS MAB230P for Anti-HIS Biosensors II-59
Pharmaco-Kinesis Bags DoD Grant for Biosensor Development II-59
Domain Therapeutics Collaborates with Universities in Canada II-59
Tokyo Electron Collaborates with imec II-59
Sensors for Medicine and Science Undergoes Name Change to
Senseonics II-59
8. FOCUS ON SELECT PLAYERS II-60Companies Developing Biosensor-Based Devices II-60Abbott Point Of Care, Inc. (US) II-60Animas Corporation (US) II-60Bio-Rad Laboratories, Inc. (US) II-60GE Healthcare Life Sciences (UK) II-61F. Hoffmann-La Roche Ltd (Switzerland) II-61LifeScan, Inc. (US) II-62Medtronic MiniMed, Inc. (US) II-62Leading Developers of Biosensor Technology II-63Abtech Scientific, Inc. (US) II-63Agamatrix, Inc. (US) II-63Cambridge Life Sciences Limited (UK) II-63EMD Millipore Corporation (US) II-63Innovative Biosensors, Inc. (US) II-64I-Sens Ltd. (UK) II-64Nova Biomedical Corp. (US) II-64PerkinElmer, Inc. (US) II-65Sigma Aldrich Corporation (US) II-65
9. GLOBAL MARKET PERSPECTIVE II-66
Table 5: World Recent Past, Current & Future Analysis for
Biosensors by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-66
Table 6: World Historic Review for Biosensors by GeographicRegion - US, Canada, Japan, Europe, Asia-Pacific (excludingJapan), and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2006 through2012 (includes corresponding Graph/Chart) II-67
Table 7: World 15-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-68
Global Biosensors Market: Analytics by Product Group/Segment II-69
Table 8: World Recent Past, Current & Future Analysis for
Medical Biosensors by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-69
Table 9: World Historic Review for Medical Biosensors byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) II-70
Table 10: World 15-Year Perspective for Medical Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-71
Table 11: World Recent Past, Current & Future Analysis forMedical Biosensors by Product Segment - Glucose Biosensors andOther Medical Biosensors Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2013 through2020 (includes corresponding Graph/Chart) II-72
Table 12: World Historic Review for Medical Biosensors by
Product Segment - Glucose Biosensors and Other Medical
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-73
Table 13: World 15-Year Perspective for Medical Biosensors byProduct Segment - Percentage Breakdown of Value Sales forGlucose Biosensors and Other Medical Biosensors Markets forYears 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-74
Table 14: World Recent Past, Current & Future Analysis for
Glucose Medical Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-75
Table 15: World Historic Review for Glucose Medical Biosensorsby Geographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) II-76
Table 16: World 15-Year Perspective for Glucose Medical
Biosensors by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) II-77
Table 17: World Recent Past, Current & Future Analysis forOther Medical Biosensors by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) II-78
Table 18: World Historic Review for Other Medical Biosensors
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-79
Table 19: World 15-Year Perspective for Other MedicalBiosensors by Geographic Region - Percentage Breakdown ofValue Sales for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets for Years 2006,2014 & 2020 (includes corresponding Graph/Chart) II-80
Table 20: World Recent Past, Current & Future Analysis for
Environmental Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-81
Table 21: World Historic Review for Environmental Biosensorsby Geographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) II-82
Table 22: World 15-Year Perspective for Environmental
Biosensors by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) II-83
Table 23: World Recent Past, Current & Future Analysis forOther Biosensors by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), and Rest of WorldMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) II-84
Table 24: World Historic Review for Other Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) II-85
Table 25: World 15-Year Perspective for Other Biosensors byGeographic Region - Percentage Breakdown of Value Sales forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan), andRest of World Markets for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) II-86III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Outlook III-1
Diabetes Monitoring Market in the US III-1
Table 26: North American Blood Glucose Strips Market
(2012): Percentage Share Breakdown of Dollar Sales of SMBG
Glucose Strips and POC Glucose Strips (includes
corresponding Graph/Chart) III-2
Table 27: North American Diabetes Prevalence Statistics byAge Group and Gender (2013E) (includes correspondingGraph/Chart) III-3
Table 28: North America Incidence of Type-1 Diabetes in
Children (2012) (includes corresponding Graph/Chart) III-3
Table 29: Number of Diabetics by Gender in the US (2013E)(in '000s) (includes corresponding Graph/Chart) III-4Diabetes in America: Key Facts and Figures III-4Rising Need for Environmental Monitoring Augurs Well forBiosensors Market III-5Product Developments/Approvals/Launches III-6Strategic Corporate Developments III-7Key Players III-8B.Market Analytics III-13Table 30: US Recent Past, Current & Future Analysis forBiosensors by Product Group/ Segment - Medical Biosensors(Glucose Biosensors and Other Medical Biosensors),Environmental Biosensors and Other Biosensors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2013 through 2020 (includes correspondingGraph/Chart) III-13
Table 31: US Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-14
Table 32: US 15-Year Perspective for Biosensors by ProductGroup/Segment - Percentage Breakdown of Value Sales forMedical Biosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-15
2. CANADA III-16
A.Market Analysis III-16
Outlook III-16
Rising Diabetes Prevalence: A Business Case of Biosensors
Market III-16
Table 33: Adult Diabetes Population by Gender in Canada
(2013) (In '000s) (includes corresponding Graph/Chart) III-16
Table 34: Adult Diabetes Population by Age Group in Canada(2013) (In '000s) (includes corresponding Graph/Chart) III-17Biosensor Research in Canada III-17Strategic Corporate Development III-17B.Market Analytics III-18Table 35: Canadian Recent Past, Current & Future Analysisfor Biosensors by Product Group/Segment - Medical Biosensors(Glucose Biosensors and Other Medical Biosensors),Environmental Biosensors and Other Biosensors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2013 through 2020 (includes correspondingGraph/Chart) III-18
Table 36: Canadian Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-19
Table 37: Canadian 15-Year Perspective for Biosensors byProduct Group/Segment - Percentage Breakdown of Value Salesfor Medical Biosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-20
3. JAPAN III-21
A.Market Analysis III-21
Overview III-21
Strategic Corporate Development III-21
B.Market Analytics III-22
Table 38: Japanese Recent Past, Current & Future Analysis
for Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-22
Table 39: Japanese Historic Review for Biosensors by ProductGroup/Segment - Medical Biosensors (Glucose Biosensors andOther Medical Biosensors), Environmental Biosensors andOther Biosensors Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2006 through 2012(includes corresponding Graph/Chart) III-23
Table 40: Japanese 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-24
4. EUROPE III-25A.Market Analysis III-25Outlook III-25Rising Prevalence of Diabetes: An Opportunity Indicator III-25Table 41: European Population and Diabetes PrevalenceStatistics (2013E) - Select Regions with High Prevalence ofDiabetes for Age Groups (20-39, 40-59, and 60-79) andGender (includes corresponding Graph/Chart) III-26Demand for Biosensor Usage in Environmental Monitoring Surges III-26Safe Drinking Water: Role of Biosensors III-27Product Approval III-28B.Market Analytics III-29Table 42: European Recent Past, Current & Future Analysisfor Biosensors by Geographic Region - France, Germany,Italy, UK, Spain, Russia and Rest of Europe MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2013 through 2020 (includes correspondingGraph/Chart) III-29
Table 43: European Historic Review for Biosensors by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-30
Table 44: European 15-Year Perspective for Biosensors byGeographic Region - Percentage Breakdown of Value Sales forFrance, Germany, Italy, UK, Spain, Russia and Rest of EuropeMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-31
Table 45: European Recent Past, Current & Future Analysis
for Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-32
Table 46: European Historic Review for Biosensors by ProductGroup/Segment - Medical Biosensors (Glucose Biosensors andOther Medical Biosensors), Environmental Biosensors andOther Biosensors Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2006 through 2012(includes corresponding Graph/Chart) III-33
Table 47: European 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-34
4a. FRANCE III-35Market Analysis III-35Table 48: French Recent Past, Current & Future Analysis forBiosensors by Product Group/ Segment - Medical Biosensors(Glucose Biosensors and Other Medical Biosensors),Environmental Biosensors and Other Biosensors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2013 through 2020 (includes correspondingGraph/Chart) III-35
Table 49: French Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-36
Table 50: French 15-Year Perspective for Biosensors byProduct Group/Segment - Percentage Breakdown of Value Salesfor Medical Biosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-37
4b. GERMANY III-38
Market Analysis III-38
Table 51: German Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-38
Table 52: German Historic Review for Biosensors by ProductGroup/Segment - Medical Biosensors (Glucose Biosensors andOther Medical Biosensors), Environmental Biosensors andOther Biosensors Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2006 through 2012(includes corresponding Graph/Chart) III-39
Table 53: German 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-40
4c. ITALY III-41Market Analysis III-41Table 54: Italian Recent Past, Current & Future Analysis forBiosensors by Product Group/ Segment - Medical Biosensors(Glucose Biosensors and Other Medical Biosensors),Environmental Biosensors and Other Biosensors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2013 through 2020 (includes correspondingGraph/Chart) III-41
Table 55: Italian Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-42
Table 56: Italian 15-Year Perspective for Biosensors byProduct Group/Segment - Percentage Breakdown of Value Salesfor Medical Biosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-43
4d. THE UNITED KINGDOM III-44
A.Market Analysis III-44
Outlook III-44
Diabetes Management - A Key Growth Driver for Biosensors Market III-44
Key Players III-44
B.Market Analytics III-46
Table 57: UK Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-46
Table 58: UK Historic Review for Biosensors by ProductGroup/Segment - Medical Biosensors (Glucose Biosensors andOther Medical Biosensors), Environmental Biosensors andOther Biosensors Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2006 through 2012(includes corresponding Graph/Chart) III-47
Table 59: UK 15-Year Perspective for Biosensors by Product
Group/Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-48
4e. SPAIN III-49Market Analysis III-49Table 60: Spanish Recent Past, Current & Future Analysis forBiosensors by Product Group/Segment - Medical Biosensors(Glucose Biosensors and Other Medical Biosensors),Environmental Biosensors and Other Biosensors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2013 through 2020 (includes correspondingGraph/Chart) III-49
Table 61: Spanish Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-50
Table 62: Spanish 15-Year Perspective for Biosensors byProduct Group/Segment - Percentage Breakdown of Value Salesfor Medical Biosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-51
4f. RUSSIA III-52
Market Analysis III-52
Table 63: Russian Recent Past, Current & Future Analysis for
Biosensors by Product Group/Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-52
Table 64: Russian Historic Review for Biosensors by ProductGroup/Segment - Medical Biosensors (Glucose Biosensors andOther Medical Biosensors), Environmental Biosensors andOther Biosensors Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2006 through 2012(includes corresponding Graph/Chart) III-53
Table 65: Russian 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-54
4g. REST OF EUROPE III-55A.Market Analysis III-55Outlook III-55F. Hoffmann-La Roche Ltd. (Switzerland) - A Major Player III-55B.Market Analytics III-56Table 66: Rest of Europe Recent Past, Current & FutureAnalysis for Biosensors by Product Group/Segment - MedicalBiosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-56
Table 67: Rest of Europe Historic Review for Biosensors by
Product Group/Segment - Medical Biosensors (Glucose
Biosensors and Other Medical Biosensors), Environmental
Biosensors and Other Biosensors Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-57
Table 68: Rest of Europe 15-Year Perspective for Biosensorsby Product Group/Segment - Percentage Breakdown of ValueSales for Medical Biosensors (Glucose Biosensors and OtherMedical Biosensors), Environmental Biosensors and OtherBiosensors Markets for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-58
5. ASIA-PACIFIC III-59
A.Market Analysis III-59
Outlook III-59
Rising Diabetes Incidence in Asia-Pacific: An Opportunity
for Biosensors III-59
Table 69: Western Pacific Population and Diabetes
Prevalence Statistics (2013E) - Select Regions with High
Prevalence of Diabetes for Various Age Groups and Gender
(includes corresponding Graph/Chart) III-60
Table 70: South East Asian Population and DiabetesPrevalence Statistics (2013E) - Select Regions with HighPrevalence of Diabetes for Various Age Groups and Gender(includes corresponding Graph/Chart) III-61B.Market Analytics III-62Table 71: Asia-Pacific Recent Past, Current & FutureAnalysis for Biosensors by Geographic Region - China andRest of Asia-Pacific Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2013 through2020 (includes corresponding Graph/Chart) III-62
Table 72: Asia-Pacific Historic Review for Biosensors by
Geographic Region - China and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-63
Table 73: Asia-Pacific 15-Year Perspective for Biosensors byGeographic Region - Percentage Breakdown of Value Sales forChina and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-64
Table 74: Asia-Pacific Recent Past, Current & Future
Analysis for Biosensors by Product Group/Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-65
Table 75: Asia-Pacific Historic Review for Biosensors byProduct Group/Segment - Medical Biosensors (GlucoseBiosensors and Other Medical Biosensors), EnvironmentalBiosensors and Other Biosensors Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) III-66
Table 76: Asia-Pacific 15-Year Perspective for Biosensors by
Product Group/Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-67
5a. CHINA III-68A.Market Analysis III-68Outlook III-68Rising Diabetes Prevalence Bodes Well for Biosensors Market III-68Government Investments in Environmental Monitoring BoostsBiosensors Market III-68Table 77: China's 12th Five Year Plan for EnvironmentalProtection: Emission Reduction Targets for the Period2011-2015 (includes corresponding Graph/Chart) III-69Strategic Corporate Development III-69B.Market Analytics III-70Table 78: Chinese Recent Past, Current & Future Analysis forBiosensors by Product Group/Segment - Medical Biosensors(Glucose Biosensors and Other Medical Biosensors),Environmental Biosensors and Other Biosensors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2013 through 2020 (includes correspondingGraph/Chart) III-70
Table 79: Chinese Historic Review for Biosensors by Product
Group/Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2012
(includes corresponding Graph/Chart) III-71
Table 80: Chinese 15-Year Perspective for Biosensors byProduct Group/Segment - Percentage Breakdown of Value Salesfor Medical Biosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) III-72
5b. REST OF ASIA-PACIFIC III-73
A.Market Analysis III-73
Outlook III-73
India III-73
Diabetic Epidemic Spurs Demand for Biosensors for Blood
Glucose Monitoring in India III-73
Focus on Biosensors' Development III-73
B.Market Analytics III-74
Table 81: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Biosensors by Product Group/Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-74
Table 82: Rest of Asia-Pacific Historic Review forBiosensors by Product Group/Segment - Medical Biosensors(Glucose Biosensors and Other Medical Biosensors),Environmental Biosensors and Other Biosensors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2006 through 2012 (includes correspondingGraph/Chart) III-75
Table 83: Rest of Asia-Pacific 15-Year Perspective for
Biosensors by Product Group/Segment - Percentage Breakdown
of Value Sales for Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets for Years 2006, 2014 & 2020
(includes corresponding Graph/Chart) III-76
6. REST OF WORLD III-77A.Market Analysis III-77Outlook III-77Rising Diabetes Population: An Opportunity Indicator III-77Table 84: Central and South American Population andDiabetes Prevalence Statistics (2013E) - Select Regionswith High Prevalence of Diabetes for Various Age Groups andGender (includes corresponding Graph/Chart) III-77
Table 85: African Population and Diabetes Prevalence
Statistics (2013) - Select Regions with High Prevalence of
Diabetes for Various Age Groups and Gender (includes
corresponding Graph/Chart) III-78
Table 86: Middle East and North African Population andDiabetes Prevalence Statistics (2013E) - Select Regionswith High Prevalence of Diabetes for Various Age Groups andGender (includes corresponding Graph/Chart) III-79B.Market Analytics III-80Table 87: Rest of World Recent Past, Current & FutureAnalysis for Biosensors by Product Group/Segment - MedicalBiosensors (Glucose Biosensors and Other MedicalBiosensors), Environmental Biosensors and Other BiosensorsMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-80
Table 88: Rest of World Historic Review for Biosensors by
Product Group/Segment - Medical Biosensors (Glucose
Biosensors and Other Medical Biosensors), Environmental
Biosensors and Other Biosensors Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-81
Table 89: Rest of World 15-Year Perspective for Biosensorsby Product Group/Segment - Percentage Breakdown of ValueSales for Medical Biosensors (Glucose Biosensors and OtherMedical Biosensors), Environmental Biosensors and OtherBiosensors Markets for Years 2006, 2014 & 2020 (includescorresponding Graph/Chart) III-82IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 83 (including Divisions/Subsidiaries - 97)
The United States (62)Canada (2)Japan (5)Europe (22)- France (1)- Germany (3)- The United Kingdom (7)- Italy (1)- Rest of Europe (10)Asia-Pacific (Excluding Japan) (6)
Read the full report: http://www.reportlinker.com/p02568579-summary/view-report.html
About Reportlinker ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-biosensors-market-300014790.html
SOURCE Reportlinker
Share this article